Biosimilars in the EU: Approval Overview and Therapeutic Areas

Key BIOS facts and Figures – 2025

Product-level Life Cycle Assessments in the Off-Patent Sector

Generic Medicines Market Review 2025 – Key findings

Biosimilar Medicines Market Review 2025 – Key findings

New Angle’s study on Securing access, improving lives. Strengthening patients’ access to medicines in Europe

Mandatory Stockpiling in the EU

Mandatory Stockpiling in the EU: Policy recommendations, solutions and alternatives

Mandatory security of supply criteria in procurement and pricing & reimbursement under the Critical Medicines Act

Factsheet on funding – Critical Medicines Act